November 3, 2025
This clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
July 24, 2025
This clinical trial aims to improve treatment for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy
March 26, 2024
This study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
January 5, 2023
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)